HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships.

Abstract
The development of drug resistance and severe side-effects has reduced the clinical efficacy of the existing anti-cancer drugs available in the market. Thus, there is always a constant need to develop newer anti-cancer drugs with minimal adverse effects. Researchers all over the world have been focusing on various alternative strategies to discover novel, potent, and target specific molecules for cancer therapy. In this direction, several heterocyclic compounds are being explored but amongst them one promising heterocycle is acridone which has attracted the attention of medicinal chemists and gained huge biological importance as acridones are found to act on different therapeutically proven molecular targets, overcome ABC transporters mediated drug resistance and DNA intercalation in cancer cells. Some of these acridone derivatives have reached clinical studies as these heterocycles have shown huge potential in cancer therapeutics and imaging. Here, the authors have attempted to compile and make some recommendations of acridone based derivatives concerning their cancer biological targets and in vitro-cytotoxicity based on drug design and novelty to increase their therapeutic potential. This review also provides some important insights on the design, receptor targeting and future directions for the development of acridones as possible clinically effective anti-cancer agents.
AuthorsTanuja T Yadav, Manikanta Murahari, G J Peters, Mayur Yc
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 239 Pg. 114527 (Sep 05 2022) ISSN: 1768-3254 [Electronic] France
PMID35717872 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Acridones
  • Antineoplastic Agents
  • acridone
Topics
  • Acridones (chemistry, pharmacology)
  • Antineoplastic Agents (chemistry, pharmacology)
  • Drug Design
  • Humans
  • Neoplasms (drug therapy)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: